Johnson Investment Counsel Inc Abbott Laboratories Transaction History

Johnson Investment Counsel Inc

  • $10.1 Billion
  • Q3 2024

A detailed history of Johnson Investment Counsel Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 997,208 shares of ABT stock, worth $112 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
997,208
Previous 998,953 0.17%
Holding current value
$112 Million
Previous $104 Million 9.53%
% of portfolio
1.12%
Previous 1.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$100.07 - $118.13 $174,622 - $206,136
-1,745 Reduced 0.17%
997,208 $114 Million
Q2 2024

Aug 08, 2024
BUY
$100.73 - $112.44 $101 Million - $112 Million
998,953 New
998,953 $104 Million
Q4 2023

Feb 07, 2024
BUY
$90.19 - $110.4 $387,636 - $474,499
4,298 Added 0.44%
976,715 $108 Million
Q3 2023

Nov 13, 2023
BUY
$95.53 - $114.62 $1.46 Million - $1.76 Million
15,324 Added 1.6%
972,417 $94.2 Million
Q2 2023

Aug 10, 2023
BUY
$100.78 - $112.29 $1.26 Million - $1.4 Million
12,499 Added 1.32%
957,093 $104 Million
Q1 2023

May 15, 2023
SELL
$96.86 - $114.01 $855,080 - $1.01 Million
-8,828 Reduced 0.93%
944,594 $95.6 Million
Q4 2022

Feb 14, 2023
BUY
$95.06 - $111.52 $1.92 Million - $2.25 Million
20,210 Added 2.17%
953,422 $105 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $670,063 - $775,807
6,925 Added 0.75%
933,212 $90.3 Million
Q2 2022

Aug 15, 2022
BUY
$102.07 - $123.37 $515,759 - $623,388
5,053 Added 0.55%
926,287 $101 Million
Q1 2022

May 11, 2022
BUY
$114.02 - $139.04 $287,786 - $350,936
2,524 Added 0.27%
921,234 $109 Million
Q4 2021

Feb 15, 2022
BUY
$115.53 - $141.46 $955,317 - $1.17 Million
8,269 Added 0.91%
918,710 $129 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $936,546 - $1.04 Million
8,028 Added 0.89%
910,441 $108 Million
Q2 2021

Aug 13, 2021
SELL
$105.79 - $124.53 $383,488 - $451,421
-3,625 Reduced 0.4%
902,413 $105 Million
Q1 2021

May 14, 2021
SELL
$108.84 - $128.23 $17.8 Million - $21 Million
-163,750 Reduced 15.31%
906,038 $109 Million
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $526,680 - $573,930
-5,016 Reduced 0.47%
1,069,788 $117 Million
Q3 2020

Nov 16, 2020
SELL
$91.64 - $111.29 $3.95 Million - $4.8 Million
-43,120 Reduced 3.86%
1,074,804 $117 Million
Q2 2020

Aug 13, 2020
SELL
$76.57 - $98.0 $1.47 Million - $1.88 Million
-19,164 Reduced 1.69%
1,117,924 $102 Million
Q1 2020

May 20, 2020
BUY
$62.82 - $91.86 $2.2 Million - $3.22 Million
35,080 Added 3.18%
1,137,088 $89.7 Million
Q4 2019

Feb 13, 2020
BUY
$78.51 - $87.4 $1.96 Million - $2.18 Million
24,995 Added 2.32%
1,102,008 $95.7 Million
Q3 2019

Nov 14, 2019
SELL
$81.84 - $88.74 $309,518 - $335,614
-3,782 Reduced 0.35%
1,077,013 $90.1 Million
Q2 2019

Aug 14, 2019
BUY
$72.88 - $85.0 $376,133 - $438,685
5,161 Added 0.48%
1,080,795 $90.9 Million
Q1 2019

May 13, 2019
SELL
$66.22 - $80.06 $2.02 Million - $2.45 Million
-30,560 Reduced 2.76%
1,075,634 $86 Million
Q4 2018

Feb 13, 2019
SELL
$65.56 - $74.27 $1.63 Million - $1.85 Million
-24,849 Reduced 2.2%
1,106,194 $80 Million
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $177,139 - $213,697
2,913 Added 0.26%
1,131,043 $83 Million
Q2 2018

Aug 14, 2018
BUY
$57.57 - $63.54 $2.21 Million - $2.44 Million
38,400 Added 3.52%
1,128,130 $68.8 Million
Q1 2018

May 15, 2018
BUY
$56.27 - $63.62 $725,714 - $820,507
12,897 Added 1.2%
1,089,730 $65.3 Million
Q4 2017

Feb 14, 2018
SELL
$53.68 - $57.47 $264,105 - $282,752
-4,920 Reduced 0.45%
1,076,833 $61.5 Million
Q3 2017

Nov 14, 2017
BUY
$48.06 - $53.64 $52 Million - $58 Million
1,081,753
1,081,753 $57.7 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email